NUP93 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.362220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.628020E-02
Normal-vs-Stage2
1.646410E-01
Normal-vs-Stage3
9.611800E-02
Normal-vs-Stage4
7.500000E-01
Stage1-vs-Stage2
1.645950E-01
Stage1-vs-Stage3
7.230400E-01
Stage1-vs-Stage4
7.806000E-02
Stage2-vs-Stage3
1.324560E-01
Stage2-vs-Stage4
2.904600E-01
Stage3-vs-Stage4
1.653410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.573610E-01
Normal-vs-AfricanAmerican
1.475220E-01
Normal-vs-Asian
1.026410E-02
Caucasian-vs-AfricanAmerican
8.626800E-01
Caucasian-vs-Asian
1.548420E-01
AfricanAmerican-vs-Asian
3.030200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.563790E-01
Normal-vs-Female
1.273600E-01
Male-vs-Female
9.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.574200E-01
Normal-vs-Age(41-60Yrs)
1.038770E-01
Normal-vs-Age(61-80Yrs)
1.190580E-01
Normal-vs-Age(81-100Yrs)
5.567800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.142200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.489600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.841200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.866560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.362400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.232800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.770160E-01
Normal-vs-Daily Drinker
1.277230E-01
Normal-vs-Weekly Drinker
2.281600E-01
Normal-vs-Occasional Drinker
4.017400E-01
Normal-vs-Social Drinker
2.002200E-01
Non Drinker-vs-Daily Drinker
7.124200E-01
Non Drinker-vs-Weekly Drinker
8.569800E-01
Non Drinker-vs-Occasional Drinker
2.110400E-01
Non Drinker-vs-Social Drinker
4.224400E-01
Daily Drinker-vs-Weekly Drinker
6.312800E-01
Daily Drinker-vs-Occasional Drinker
1.231770E-01
Daily Drinker-vs-Social Drinker
2.563000E-01
Weekly Drinker-vs-Occasional Drinker
3.645000E-01
Weekly Drinker-vs-Social Drinker
5.839200E-01
Occasional Drinker-vs-Social Drinker
6.485800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.960200E-01
Normal-vs-Grade 2
8.858400E-01
Normal-vs-Grade 3
8.139800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.69179999999214E-05
Grade 1-vs-Grade 3
1.8720499999958E-05
Grade 1-vs-Grade 4
8.960200E-01
Grade 2-vs-Grade 3
1.273150E-01
Grade 2-vs-Grade 4
8.858400E-01
Grade 3-vs-Grade 4
8.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.180000E-01
Normal-vs-NonDiabetic
1.075170E-01
Diabetic-vs-NonDiabetic
7.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.557500E-02
Normal-vs-NoPancreatitis
1.418040E-01
Pancreatitis-vs-NoPancreatitis
9.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.351500E-02
Normal-vs-N1
1.764600E-01
N0-vs-N1
6.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.288400E-01
Normal-vs-TP53-NonMutant
3.830400E-02
TP53-Mutant-vs-TP53-NonMutant
2.22359999968447E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
